Q2 well in line with our expectations Innofactor reported its Q2 results, which were well in line with our expectations.
Calliditas Therapeutics har tecknat ett samarbetsavtal med STADA för läkemedelskandidaten Nefecon på...
Badrumskoncernen Svedbergs fortsätter att leverera stark tillväxt och kraftiga resultatförbättringar...
Redeye sees a solid Q2 from Sdiptech, with strong organic sales growth, somewhat soft margins, and an EBITA in line with our forecasts.
SDS publicerade idag den 22 juli 2021 sin delårsrapport för andra kvartalet 2021.
Sdiptech’s Q2 2021 report was overall ahead of our estimates, driven by both focus segments Water & ...
The German private company Stada is, in our view, a resourceful partner with a strategic interest in expanding the speciality pharma market ...
Tillväxt y/y Arises omsättning i Q2 uppgick till 36 mkr (30) och EBITDA 12 mkr (6).
Lönsam tillväxt på rekordnivåer Plejd redovisade en nettoomsättning för det andra kvartalet 2021 mot...
Actic Group, a leading northern-European fitness club operator, reported Q2 sales in line with our expectations at SEK 138m (we estimated SE...
Q2 details Net sales SEK 3,551m (6% vs ABGSC 3,348m and 9% vs cons 3,270m), Gross profit SEK 945m (%...
Innofactor’s Q2 results were as expected. Net sales amounted to EUR 17.
No surprises in Q2 SRV reported Q2 results that were fairly well in line with expectations.
Redeye comments further on Evolution's second-quarter report of 2021 regarding their managements exe...
Recurring PTP of SEK 70m, 8% above ABGSCe Rental income was SEK 160m in Q2, in line with ABGSCe.
2’21 marked by lower activity, electricity income and winds Arise delivered a weak Q2 report, with sales below expectations at SEK 36m (-16%...
Redeye will likely increase its forecasts and Base case slightly, following a Q2 report showing a so...
Redeye comments on Safeture's Q2'21 report, which was stable sales and ARR-wise, although slightly b...
Redeye raises its forecasts and Base case for ZetaDisplay following a solid Q2 report showing a market rebound and improved internal efficie...
Guidance upgraded pre-Q2 after solid quarter Vaisala reports its Q2 results on July 23rd.
While Q2 was slightly below our estimates, focus is on the Indra order for three satellites, a demon...
Redeye provides an extended research note to discuss the top line deviation, PrivX momentum, and impressive ARR / subscription sales figures...
Q2 margins declined pretty much as expected Sales mix (tilt to carbon fibers) as well as volumes con...
Redeye comments on Evolution’s report of the second quarter of 2021.
SRV's net sales in Q2 amounted to EUR 218.0m, below our and consensus estimates (EUR 232.
Atria's strong Q2 results included adjusted EBIT of EUR 12.
Arbitration proceedings outcome to burden Q2 results Consti will report its Q2 results on July 23rd.
Q2 results beat extremely challenging comps Nordic Waterproofing (NWG) continues to beat expectations, with yet another exceptional quarter ...
EBITDA likely up q-o-q on higher volumes and prices We estimate Q2’21 EBITDA of SEK 88m, up from SEK...
Q2 results Sales SEK 2,786m (-2% vs ABGSCe 2,850m, -3% vs.
